Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

100.18USD
22 Apr 2014
Price Change (% chg)

$0.18 (+0.18%)
Prev Close
$100.00
Open
$100.05
Day's High
$100.75
Day's Low
$99.76
Volume
2,046,513
Avg. Vol
2,652,432
52-wk High
$100.75
52-wk Low
$82.12

JNJ.N

Chart for JNJ.N

About

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products... (more)

Overall

Beta: 0.59
Market Cap (Mil.): $283,341.50
Shares Outstanding (Mil.): 2,828.32
Dividend: 0.66
Yield (%): 2.64

Financials

  JNJ.N Industry Sector
P/E (TTM): 19.15 32.71 32.86
EPS (TTM): 5.23 -- --
ROI: -- 19.60 18.86
ROE: -- 20.30 19.62
Search Stocks

India Morning Call-Global Markets

NEW YORK - U.S. stocks ended a volatile session higher on Tuesday, lifted by gains in such blue-chip names as Coca-Cola and Johnson & Johnson, though persistent weakness in momentum names limited the Nasdaq's advance.

15 Apr 2014

Wall Street ends higher as blue chips rally; Intel up late

NEW YORK - U.S. stocks ended a volatile session higher on Tuesday, lifted by gains in such blue-chip names as Coca-Cola and Johnson & Johnson, though persistent weakness in momentum names limited the Nasdaq's advance.

15 Apr 2014

US STOCKS-Wall St ends higher as blue chips rally; Intel up late

* Dow up 0.6 pct; S&P 500 up 0.7 pct; Nasdaq up 0.3 pct (Updates to close, adds gains in Intel and Yahoo after the bell on results )

15 Apr 2014

US STOCKS SNAPSHOT-Wall St gets lift from Coca-Cola; Nasdaq lags

NEW YORK, April 15 - U.S. stocks ended higher after a volatile session on Tuesday, lifted by gains in Coca-Cola and Johnson & Johnson, though weakness in Apple, Tesla and Netflix limited the Nasdaq's advance.

15 Apr 2014

US STOCKS-Wall St falls as momentum shares sink again

* Tesla and Netflix slide; social media, biotech stocks drop

15 Apr 2014

J&J beats forecasts as sales of new drugs shine

- Johnson & Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view.

15 Apr 2014

UPDATE 4-J&J beats forecasts as sales of new drugs shine

(Adds J&J comment on weak medical device sales, updates shares)

15 Apr 2014

US STOCKS-Wall St dips as data, sinking momentum shares offset earnings

* CPI edges higher, Empire State manufacturing misses expectations

15 Apr 2014

US STOCKS-Wall St to edge higher after earnings, data

* CPI edges higher, Empire State manufacturing misses expectations

15 Apr 2014

J&J beats forecasts, helped by new medicines

April 15 - Johnson & Johnson on Tuesday reported quarterly earnings well above Wall Street expectations, as strong sales of new prescription drugs offset weak sales of consumer products.

15 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks